Varian, A Siemens Healthineers Company

This study aimed to see if a more personalized form of radiation therapy, adjusted daily, could reduce severe side effects like cough, shortness of breath, and trouble swallowing for people with stage III non-small cell lung cancer. It planned to compare this daily adaptive appro…

This study is testing a new imaging technology called HyperSight to see if it can take clearer pictures during radiation therapy. The goal is to help doctors more accurately target cancer cells while better protecting healthy tissue. About 40 adults with head and neck, breast, lu…

This trial is testing a more precise, daily-adapted form of radiation therapy for muscle-invasive bladder cancer. The main goal is to see if this method causes fewer severe intestinal side effects, like diarrhea, compared to standard radiation. It involves 110 participants and fo…